Sec Form 13D Filing - Vivo Ventures V LLC filing for SOLENO THERAPEUTICS INC PA (SLNO) - 2020-06-11

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

  

Under the Securities Exchange Act of 1934

(Amendment No. 6) *

 

SOLENO THERAPEUTICS, INC.

(Name of Issuer)

 

Common stock, par value $0.001 per share

(Title of Class of Securities)

 

834203200

(CUSIP Number)

 

Frank Kung

Vivo Capital LLC

192 Lytton Avenue

Palo Alto, CA 94301

Telephone: (650) 688-0818

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

June 9, 2020

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ☐

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

  

 

 

 

 

   

1

NAME OF REPORTING PERSON

 

Vivo Ventures V, LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨
  (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS                       OO
5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) o

6 CITIZENSHIP OR PLACE OF ORGANIZATION                       State of Delaware
       

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

7 SOLE VOTING POWER 836,137 (1)
8 SHARED VOTING POWER 0
9 SOLE DISPOSITIVE POWER 836,137 (1)
10 SHARED DISPOSITIVE POWER 0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

836,137 (1)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

¨

   
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

1.8 %(2)

   
14 TYPE OF REPORTING PERSON OO

   

(1)The securities represent warrants to acquire 836,137 shares of Common Stock of Soleno Therapeutics, Inc. (the “Issuer”), which are exercisable within 60 days after the reporting date. The warrants are held of record by Vivo Ventures Fund V, L.P. and Vivo Ventures V Affiliates Fund, L.P. Vivo Ventures V, LLC is the general partner of Vivo Ventures Fund V, L.P. and Vivo Ventures V Affiliates Fund, L.P.
(2)Based on a total of 44,710,790 shares of Common Stock of the Issuer outstanding as of May 8, 2020, as reported on the Issuer’s quarterly report on Form 10-Q for the quarter ended March 31, 2020, filed with the Securities and Exchange Commission (the “SEC”) on May 12, 2020.

 

2

 

 

1

NAME OF REPORTING PERSON

 

Vivo Capital LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨
  (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS                       OO
5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) o

6 CITIZENSHIP OR PLACE OF ORGANIZATION                      State of Delaware
       

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

 

7 SOLE VOTING POWER 14,080 (1)
8 SHARED VOTING POWER 0
9 SOLE DISPOSITIVE POWER 14,080 (1)
10 SHARED DISPOSITIVE POWER 0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

14,080 (1)

12

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

¨

   
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

0.03%(2)

   
14 TYPE OF REPORTING PERSON OO

   

(1)The securities represent shares of Common Stock held of record by Vivo Capital LLC.
(2)Based on a total of 44,710,790 shares of Common Stock of the Issuer outstanding as of May 8, 2020, as reported on the Issuer’s quarterly report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 12, 2020.

 

3

 

  

Explanatory Note

 

This Amendment No. 6 (the “Amendment No. 6”) amends and supplements the statements on Schedule 13D, filed on March 13, 2017, Amendment No. 1 to Schedule 13D, filed on December 18, 2017, Amendment No. 2 to Schedule 13D, filed on January 15, 2019, Amendment No. 3, filed on November 4, 2019, Amendment No. 4, filed on December 3, 2019 and Amendment No. 5 filed on December 9, 2019 (collectively, the “Prior 13Ds”). Except as specifically provided herein, this Amendment No. 6 does not modify any of the information previously reported on Prior 13Ds. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms on Prior 13Ds.

 

Item 4. Purpose of Transaction

 

Item 4 of the Statement is hereby amended to add the following:

 

The Reporting Persons sold the number of shares set forth below on the respective dates set forth below.

 

Date   Number of Shares Sold   Held of Record By
22-Jan-2020   78,103   Vivo Ventures Fund V, L.P.
22-Jan-2020   918   Vivo Ventures V Affiliates Fund, L.P.
23-Jan-2020   28,482   Vivo Ventures Fund V, L.P.
23-Jan-2020   335   Vivo Ventures V Affiliates Fund, L.P.
24-Jan-2020   16,773   Vivo Ventures Fund V, L.P.
24-Jan-2020   197   Vivo Ventures V Affiliates Fund, L.P.
27-Jan-2020   22,510   Vivo Ventures Fund V, L.P.
27-Jan-2020   264   Vivo Ventures V Affiliates Fund, L.P.
13-Apr-2020   7,045   Vivo Ventures Fund V, L.P.
13-Apr-2020   83   Vivo Ventures V Affiliates Fund, L.P.
14-Apr-2020   9,074   Vivo Ventures Fund V, L.P.
14-Apr-2020   107   Vivo Ventures V Affiliates Fund, L.P.
15-Apr-2020   7,215   Vivo Ventures Fund V, L.P.
15-Apr-2020   85   Vivo Ventures V Affiliates Fund, L.P.
16-Apr-2020   8,580   Vivo Ventures Fund V, L.P.
16-Apr-2020   101   Vivo Ventures V Affiliates Fund, L.P.
17-Apr-2020   2,509   Vivo Ventures Fund V, L.P.
17-Apr-2020   29   Vivo Ventures V Affiliates Fund, L.P.
20-Apr-2020   99   Vivo Ventures Fund V, L.P.
20-Apr-2020   1   Vivo Ventures V Affiliates Fund, L.P.
24-Apr-2020   5,378   Vivo Ventures Fund V, L.P.
24-Apr-2020   63   Vivo Ventures V Affiliates Fund, L.P.
27-Apr-2020   593   Vivo Ventures Fund V, L.P.
27-Apr-2020   7   Vivo Ventures V Affiliates Fund, L.P.
29-Apr-2020   14,748   Vivo Ventures Fund V, L.P.
29-Apr-2020   173   Vivo Ventures V Affiliates Fund, L.P.

 

4

 

 

Date   Number of Shares Sold   Held of Record By
30-Apr-2020   7,054   Vivo Ventures Fund V, L.P.
30-Apr-2020   83   Vivo Ventures V Affiliates Fund, L.P.
1-May-2020   11,070   Vivo Ventures Fund V, L.P.
1-May-2020   130   Vivo Ventures V Affiliates Fund, L.P.
4-May-2020   41,512   Vivo Ventures Fund V, L.P.
4-May-2020   488   Vivo Ventures V Affiliates Fund, L.P.
5-May-2020   56,388   Vivo Ventures Fund V, L.P.
5-May-2020   662   Vivo Ventures V Affiliates Fund, L.P.
6-May-2020   18,874   Vivo Ventures Fund V, L.P.
6-May-2020   222   Vivo Ventures V Affiliates Fund, L.P.
7-May-2020   19,768   Vivo Ventures Fund V, L.P.
7-May-2020   232   Vivo Ventures V Affiliates Fund, L.P.
8-May-2020   11,149   Vivo Ventures Fund V, L.P.
8-May-2020   131   Vivo Ventures V Affiliates Fund, L.P.
11-May-2020   15,118   Vivo Ventures Fund V, L.P.
11-May-2020   178   Vivo Ventures V Affiliates Fund, L.P.
12-May-2020   14,436   Vivo Ventures Fund V, L.P.
12-May-2020   170   Vivo Ventures V Affiliates Fund, L.P.
13-May-2020   17,544   Vivo Ventures Fund V, L.P.
13-May-2020   206   Vivo Ventures V Affiliates Fund, L.P.
14-May-2020   21,448   Vivo Ventures Fund V, L.P.
14-May-2020   252   Vivo Ventures V Affiliates Fund, L.P.
15-May-2020   8,648   Vivo Ventures Fund V, L.P.
15-May-2020   102   Vivo Ventures V Affiliates Fund, L.P.
18-May-2020   11,370   Vivo Ventures Fund V, L.P.
18-May-2020   134   Vivo Ventures V Affiliates Fund, L.P.
19-May-2020   22,405   Vivo Ventures Fund V, L.P.
19-May-2020   263   Vivo Ventures V Affiliates Fund, L.P.
20-May-2020   53,377   Vivo Ventures Fund V, L.P.
20-May-2020   627   Vivo Ventures V Affiliates Fund, L.P.
21-May-2020   12,397   Vivo Ventures Fund V, L.P.
21-May-2020   146   Vivo Ventures V Affiliates Fund, L.P.
22-May-2020   24,145   Vivo Ventures Fund V, L.P.
22-May-2020   284   Vivo Ventures V Affiliates Fund, L.P.
26-May-2020   23,411   Vivo Ventures Fund V, L.P.
26-May-2020   275   Vivo Ventures V Affiliates Fund, L.P.
27-May-2020   33,636   Vivo Ventures Fund V, L.P.
27-May-2020   395   Vivo Ventures V Affiliates Fund, L.P.
28-May-2020   25,105   Vivo Ventures Fund V, L.P.
28-May-2020   295   Vivo Ventures V Affiliates Fund, L.P.
29-May-2020   6,919   Vivo Ventures Fund V, L.P.
29-May-2020   81   Vivo Ventures V Affiliates Fund, L.P.
1-Jun-2020   23,727   Vivo Ventures Fund V, L.P.
1-Jun-2020   279   Vivo Ventures V Affiliates Fund, L.P.
2-Jun-2020   24,650   Vivo Ventures Fund V, L.P.
2-Jun-2020   290   Vivo Ventures V Affiliates Fund, L.P.
3-Jun-2020   14,431   Vivo Ventures Fund V, L.P.
3-Jun-2020   170   Vivo Ventures V Affiliates Fund, L.P.
4-Jun-2020   11,366   Vivo Ventures Fund V, L.P.
4-Jun-2020   134   Vivo Ventures V Affiliates Fund, L.P.
5-Jun-2020   198   Vivo Ventures Fund V, L.P.
5-Jun-2020   2   Vivo Ventures V Affiliates Fund, L.P.
9-Jun-2020   1,403,619   Vivo Ventures Fund V, L.P.
9-Jun-2020   16,486   Vivo Ventures V Affiliates Fund, L.P.

 

5

 

 

Item 5. Interest in Securities of the Issuer

 

(a) The information requested by this paragraph is incorporated herein by reference to the information provided on the cover pages to this Amendment No. 6.

 

(b) The information requested by this paragraph is incorporated herein by reference to the information provided on the cover pages to this Amendment No. 6.

 

(c) Except as disclosed herein and in Prior 13Ds, none of the Reporting Persons has effected any other transactions in the securities of the Issuer during the past 60 days.

 

(d) Not applicable.

 

(e) Not applicable.

  

6

 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

June 11, 2020

 

  Vivo Ventures V, LLC
   
  By: /s/ Frank Kung
  Name: Frank Kung
  Title: Managing Member
   
  Vivo Capital LLC
   
  By: /s/ Frank Kung
  Name: Frank Kung
  Title: Managing Member

 

 

7